Corbus Pharmaceuticals Holdings Inc expected to post a loss of $3.10 a share - Earnings Preview

Corbus Pharmaceuticals Holdings

04/08/2023 17:10

* Corbus Pharmaceuticals Holdings Inc  CRBP.OQ   CRBP.O  is
expected to show no change in quarterly revenue when it reports 
results on August 7 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Corbus
Pharmaceuticals
Holdings Inc is for a loss of $3.10 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Corbus
Pharmaceuticals Holdings Inc is $71​, above​ its last closing
price of $6.70. ​​​

This summary was machine generated August 4 at 16:10 GMT.  All
figures in US dollars  unless otherwise stated